High risk of self-harm in first year of dementia diagnosis: UNSW study
Patients recently diagnosed with dementia are at increased risk of self-harm, especially within the first 6-12 months of diagnosis, a large Australian study shows. Those…
Tag: Dementia
High CV burden ‘magnifies dementia risk’ in adults with focal epilepsy
Cardiovascular disease risk modification may be critical to preventing adults with focal epilepsy from developing dementia in later life, UK doctors report. The advice follows…
Alzheimer’s cure: Have we seen the resurrection of the amyloid hypothesis?
Billions of dollars in research. Hundreds of failed experiments. Half a dozen competing theories. The search for an effective dementia treatment has proven expensive and…
Male footballers 60% more likely to develop Alzheimer’s
Elite male soccer players are 60% more likely to develop Alzheimer’s disease or other dementias compared with the general population, a study shows. But goalkeepers do…
Widely used dementia screening tool updated for patients with impaired hearing
Doctors have successfully adapted a widely used cognitive screening test to make it suitable for patients with hearing loss emphasising written instructions rather than spoken…
FDA approves second drug for Alzheimer’s disease
The US Food and Drug Administration has approved a second drug for Alzheimer’s disease, lecanemab (Leqembi), despite reports of rare brain bleeds linked to use…
Hope vs hype: Doctors split over ‘game-changing’ experimental Alzheimer’s drug
“Impressive”. “Remarkable”. “Game-changing”. There was no shortage of praise for the experimental dementia drug lecanemab following the release of phase III trial results late last year. × Welcome…
Psychotherapy for anxiety in over-65s may lower dementia risk
Improving anxiety symptoms in older adults using psychotherapy is associated with significant long-term reductions in dementia risk, shows a large real-world study. Analysis of data…
Hearing aid use linked to reduced cognitive decline: review
For individuals with hearing loss, use of hearing aid devices is associated with a reduced risk for long-term cognitive decline, according to a review published…
Experimental drug ‘reduces brain amyloid burden’ in early Alzheimer’s disease
For patients with early Alzheimer’s disease, lecanemab reduced markers of amyloid and resulted in moderately less decline in cognition and function at 18 months, according…
